Clinical Trial Update: Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral probiotics for secondary bacterial pneumonia in severe COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia

Snippet

Sponsor: Universidade de Passo Fundo | Conditions: COVID-19 Lower Respiratory Infection, Microbial Colonization | Phase 2 | Status: COMPLETED